References
1. Guan W, Ni Z, Hu Y, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med . February 2020:NEJMoa2002032. doi:10.1056/NEJMoa2002032
2. Singhania N, Bansal S, Singhania G. An Atypical Presentation of Novel Coronavirus Disease 2019 (COVID-19). Am J Med . April 2020. doi:10.1016/j.amjmed.2020.03.026
3. Singhania N, Bansal S, Nimmatoori DP, Ejaz AA, McCullough PA, Singhania G. Current Overview on Hypercoagulability in COVID-19.Am J Cardiovasc Drugs . 2020;20(5):393-403. doi:10.1007/s40256-020-00431-z
4. Wichmann D, Sperhake J-P, Lütgehetmann M, et al. Autopsy Findings and Venous Thromboembolism in Patients With COVID-19. Ann Intern Med . May 2020. doi:10.7326/M20-2003
5. Ranucci M, Ballotta A, Di Dedda U, et al. The procoagulant pattern of patients with COVID‐19 acute respiratory distress syndrome. J Thromb Haemost . April 2020. doi:10.1111/jth.14854
6. Klok FA, Kruip MJHA, van der Meer NJM, et al. Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res . 2020;191. doi:10.1016/j.thromres.2020.04.013
7. Spyropoulos AC, Levy JH, Ageno W, et al. Scientific and Standardization Committee Communication: Clinical Guidance on the Diagnosis, Prevention and Treatment of Venous Thromboembolism in Hospitalized Patients with COVID‐19. J Thromb Haemost . May 2020:jth.14929. doi:10.1111/jth.14929